ArticleCancer immunology, immunotherapy : CII2022

An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors.

Pu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.